A Phase 1 Pharmacokinetic And Pharmacodynamic Study Of PF-03732010 In Patients With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 21 Feb 2012
At a glance
- Drugs PF 3732010 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Biomarker
- 04 Jan 2012 Actual patient number changed from 44 to 43 as reported by ClinicalTrials.gov.
- 12 Apr 2011 Actual patient numbers reported as 42 by ClinicalTrials.gov
- 12 Apr 2011 Status changed from active, no longer recruiting to completed, as reported by the ClinicalTrials.gov record